New hope for heart attack recovery: drug trial targets cholesterol and inflammation

This study tested if adding the cholesterol-lowering drug evolocumab to standard treatment could help people who recently had a heart attack. Researchers wanted to see if the drug could better control cholesterol, reduce harmful inflammation in the heart and blood vessels, and improve heart function. The trial involved 100 participants who were randomly assigned to receive either evolocumab or a placebo injection during their hospital stay, in addition to their usual care.